Phase I Trial of rhIL-12 and rHuIFN-a2b in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
Phase of Trial: Phase I
Latest Information Update: 20 Mar 2013
At a glance
- Drugs Interferon alpha-2b (Primary) ; Interleukin-12 (Primary)
- Indications Malignant melanoma; Renal cancer
- Focus Adverse reactions
- 08 Aug 2005 New trial record.